Resourcepath, LLC
Sterling, VA
- UEI
- PAJNWLGPK753
- CAGE
- 7AR38
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- SBA certifications
-
Women-Owned Small Business· Current
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 45945 Trefoil Ln #175, Sterling, VA 20166, USA
- Website
- resourcepath.net
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $746,197 |
| FY2023 | $3,500 |
Contract awards
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Children's Health Care | R37CA244940 | $111,300 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Bioreference Health LLC | Elmwood Park, NJ | 621511 Medical Laboratories |
| Advanced Biomedical Laboratories L.l.c | Cinnaminson, NJ | 621511 Medical Laboratories |
| Associated Pathologists, LLC | Brentwood, TN | 621511 Medical Laboratories |
| Exonova Biosciences LLC | Bethesda, MD | 541690 Other Scientific and Technical Consulting Services |
| Ascp | Chicago, IL | 813920 Professional Organizations |
About the company
Resourcepath, LLC, doing business as Resourcepath LLC, is a corporate entity registered as a Woman-Owned Small Business that provides expertise, knowledge, and clinical testing in pathology and oncology. According to its website, Resourcepath operates a core laboratory staffed by pathologists and scientists performing disease research in Northern Virginia.
Resourcepath, LLC has been awarded prime federal contracts to provide pre-clinical diagnostic services and support the development of in vitro diagnostic products for the detection, identification, and characterization of human infectious agents. It was recently awarded a $3,500 firm fixed price delivery order by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases under the DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for pre-clinical diagnostic services program support to be performed in Sterling, Virginia through June 2030. No set-aside designation or major subcontractors were indicated.
Resourcepath, LLC has also received prime federal grant awards, such as a $224,679 Project Grant from the Department of Health and Human Services National Institutes of Health National Cancer Institute in 2019 for "DEVELOPMENT AND VALIDATION OF LIQUID BIOPSY DDPCR AND NEXT GENERATION SEQUENCING ASSAYS FOR DIFFUSE MIDLINE GLIOMA, K27M VARIANT." The grant award funded research and development activities related to liquid biopsy diagnostic assays for a specific type of cancer.
Resourcepath, LLC holds an Indefinite Delivery Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases under the DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM. The single-award contract has a potential value of $12 million and period of performance through June 2030. Under this contract, Resourcepath was issued the aforementioned $3,500 firm fixed price delivery order for pre-clinical diagnostic services program support. The contract's scope includes providing diagnostic pre-clinical services to support the development of in vitro diagnostic products, such as product development processes and documentation, recombinant proteins and monoclonal antibodies, biochemical reagents, clinical specimens and bacterial isolates, next-generation sequencing, immunoassays and nucleic acid amplification assays, and pre-pilot and pilot-scale GMP manufacturing services.
SBA capabilities narrative
We provide pathology expertise, histology and molecular diagnostic support to academic institutions and private companies. Founded by pathologists who are also disease focused researchers, our services are particularly helpful for validating diagnoses and supporting subsequent histologic and/or molecular characterization. Our laboratory has performed more than 80,000 COVID RT-PCR tests to assist local government entities, long-term-care facilities, schools, companies and other organizations, meet their specific needs for medical, outbreak and surveillance testing. ResourcePath provides testing solutions that are best in class, are performed by experienced molecular technologists and are reviewed by a physician.
Quick answers
Is Resourcepath, LLC registered in SAM.gov?
Yes. Resourcepath, LLC's SAM.gov registration is active through January 21, 2027.
Which SBA certifications does Resourcepath, LLC hold?
Resourcepath, LLC holds Women-Owned Small Business certification from the SBA.
How much has Resourcepath, LLC received in federal contracts?
Federal contracts obligated $749,697 to Resourcepath, LLC in fiscal years 2023 through 2027.
What is Resourcepath, LLC's most recent federal award?
Resourcepath, LLC's most recent federal contract award is Diagnostics pre-clinical services program (75N93024F00001), from National Institute of Allergy and Infectious Diseases (NIH), on June 20, 2023.
On GovTribe
See Resourcepath, LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors